title: Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study.
abstract: BACKGROUND
  Prescription opioid use disorders are the second most common drug use disorder behind only cannabis use disorders. Despite this, very little is known about the help-seeking behavior among individuals with these disorders.
  
  
  METHODS
  The sample included respondents of the Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) with a lifetime diagnosis of prescription drug use disorders (N=623). Unadjusted and adjusted hazard ratios are presented for time to first treatment-seeking by sociodemographic characteristics and comorbid psychiatric disorders.
  
  
  RESULTS
  The lifetime cumulative probability of treatment seeking was 42% and the median delay from prescription drug use disorder onset to first treatment was 3.83 years. Having an earlier onset of prescription opioid use disorder and a history of bipolar disorder, major depression disorder, specific phobia and cluster B personality disorders predicted shorter delays to treatment.
  
  
  CONCLUSIONS
  Although some comorbid psychiatric disorders increase the rate of treatment-seeking and decrease delays to first-treatment contact rates of treatment-seeking for prescription drug use disorder are low, even when compared with rates of treatment for other substance use disorders. Given the high prevalence and adverse consequences of prescription drug use disorder, there is a need to improve detection and treatment of prescription opioid use disorder.
authors.affiliation: Department of Psychiatry, New York State Psychiatric Institute/College of Physicians and Surgeons, Columbia University, New York, NY 10032, United States. cb255@columbia.edu
authors.forename: Carlos
authors.initials: C
authors.lastname: Blanco
authors.forename: Miren
authors.initials: M
authors.lastname: Iza
authors.forename: Robert P
authors.initials: RP
authors.lastname: Schwartz
authors.forename: Claudia
authors.initials: C
authors.lastname: Rafful
authors.forename: Shuai
authors.initials: S
authors.lastname: Wang
authors.forename: Mark
authors.initials: M
authors.lastname: Olfson
mesh_terms: D000293:Adolescent; D000328:Adult; D000701:Analgesics, Opioid / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D009293:Opioid-Related Disorders / Q000453:epidemiology* / Q000523:psychology / Q000628:therapy*; D010342:Patient Acceptance of Health Care / Q000523:psychology; D011237:Predictive Value of Tests; D055553:Prescription Drugs / Q000009:adverse effects; D011336:Probability; D057566:Self Report; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000701:Analgesics, Opioid; D055553:Prescription Drugs